Integrated Filing — IndAS



General information about company

Scrip Code 506109
NSE Symbol GENESYS
MSEI Symbol NOTLISTED
ISIN INE727B01026
Name of company Genesys International Corporation Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 13-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 06-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Geographical information system
Start date and time of board meeting 13-11-2025   16:10:00
End date and time of board meeting 13-11-2025   17:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 7,694.64 14,781.40
Other income 384.18 511.58
Total income 8,078.82 15,292.98
2 Expenses
(a) Cost of materials consumed 2,065.74 3,867.03
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 1,779.69 3,448.82
(e) Finance costs 310.37 628.66
(f) Depreciation, depletion and amortisation expense 1,562.03 3,105.02
(f) Other Expenses
1 Other Expenses 849.74 1,516.18
Total other expenses 849.74 1,516.18
Total expenses 6,567.57 12,565.71
3 Total profit before exceptional items and tax 1,511.25 2,727.27
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,511.25 2,727.27
6 Tax expense
7 Current tax 304.08 817.48
8 Deferred tax 2.00 7.00
9 Total tax expenses 306.08 824.48
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,205.17 1,902.79
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,205.17 1,902.79
17 Other comprehensive income net of taxes 330.03 277.68
18 Total Comprehensive Income for the period 1,535.20 2,180.47
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 1,200.10 1,912.03
Total profit or loss, attributable to non-controlling interests 5.07 (9.25)
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 1,524.70 2,184.34
Total comprehensive income for the period attributable to owners of parent non-controlling interests 10.51 3.87
21 Details of equity share capital
Paid-up equity share capital 2,085.95 2,085.95
Face value of equity share capital 5 5
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 2.89 4.62
Diluted earnings (loss) per share from continuing operations 2.88 4.6
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 2.89 4.62
Diluted earnings (loss) per share from continuing and discontinued operations 2.88 4.6
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) The Unaudited consolidated financials results of Genesys International Corporation Limited the parent company and its subsidaries together referred as Group have been prepared in accordance with Indian Accounting Standards Ind AS notified under section 133 of the Companies Act 2013 read together with the companies Indian Accounting Standards Rules 2015 as amended and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements 2015 as amended The unaudited consolidated financial results for the quarter and half year ended 30 September 2025 were reviewed by the Audit Committee and approved by the Board of Directors of Genesys International Corporation Limited the Company at their respective meeting held on November 13 2025 and are available on the company website and BSE and NSE The statutory auditor of the company have carried out limited review on the above results in terms of regulation 33 of the SEBI Listing Obligation and Disclosure Requirements Regulations 2015 the Regulation as amended and expressed an unmodified review conclusion On 17th May 2025 the Parent company has by way of Qualified Institutional Placement QIP in accordance with SEBI Issue of Capital and Disclosure Requirements Regulations 2018 as amended and section 42 and 62 of the Companies Act 2013 allotted 1739625 equity shares of face value of Rs 5 per share at a price of Rs632.32 per share aggregating to Rs11000 lakhs The funds raised by the Company pursuant to QIP have been partially utilized in accordance with the Use of Proceeds mentioned in the placement document of QIP for the period ended 30th September 2025 and unutilized balances as at 30th September 2025 have been temporarily invested Previous period figures have been regrouped re-classified wherever necessary



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 5,497.10
Capital work-in-progress 362.21
Investment property 0.00
Goodwill 0.00
Other intangible assets 4,581.75
Intangible assets under development 16,411.47
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current 0.00
Loans, non-current 24.80
Other non-current financial assets 2,279.52
Total non-current financial assets 2,304.32
Deferred tax assets (net) 1,118.04
Other non-current assets 1,487.20
Total non-current assets 31,762.09
2 Current assets
Inventories 0.00
Current financial asset
Current investments 0.00
Trade receivables, current 20,937.63
Cash and cash equivalents 2,955.93
Bank balance other than cash and cash equivalents 7,550.70
Loans, current 3.60
Other current financial assets 26,138.11
Total current financial assets 57,585.97
Current tax assets (net) 97.85
Other current assets 2,578.32
Total current assets 60,262.14
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 92,024.23
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 2,085.95
Other equity 66,249.05
Total equity attributable to owners of parent 68,335.00
Non controlling interest 150.45
Total equity 68,485.45
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 918.19
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 551.90
Total non-current financial liabilities 1,470.09
Provisions, non-current 996.75
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 2,466.84
Current liabilities
Current financial liabilities
Borrowings, current 12,731.72
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 522.10
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 2,872.09
Total Trade payable 3,394.19
Other current financial liabilities 3,356.86
Total current financial liabilities 19,482.77
Other current liabilities 581.95
Provisions, current 248.30
Current tax liabilities (Net) 758.92
Deferred government grants, Current 0.00
Total current liabilities 21,071.94
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 23,538.78
Total equity and liabilites 92,024.23
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of net defined benefit plans (net of taxes) 1804000 1577000
Total Amount of items that will not be reclassified to profit and loss 18.04 15.77
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Exchange differences on translation of financial statements of foreign operations 31199000 26191000
Total Amount of items that will be reclassified to profit and loss 311.99 261.91
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 330.03 277.68



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,727.27
Adjustments for reconcile profit (loss)
Adjustments for finance costs 628.66
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current 1,247.87
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,706.15)
Adjustments for decrease (increase) in other non-current assets (205.83)
Adjustments for other financial assets, non-current 40.21
Adjustments for other financial assets, current (3,941.45)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (465.33)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (166.17)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 3,105.02
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (12.53)
Adjustments for provisions, non-current 50.38
Adjustments for other financial liabilities, current 129.27
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (22.66)
Adjustments for dividend income 0.00
Adjustments for interest income 274.50
Adjustments for share-based payments 103.63
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 178.06
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (1,311.52)
Net cash flows from (used in) operations 1,415.75
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 1,459.77
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (44.02)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 37.97
Purchase of property, plant and equipment 1,154.54
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 40.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 1,215.33
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 180.18
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (7,479.08)
Net cash flows from (used in) investing activities (9,670.80)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 10,353.14
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 134.62
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 3,153.49
Repayments of borrowings 512.63
Payments of lease liabilities 280.52
Dividends paid 0.00
Interest paid 561.36
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 12,286.74
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2,571.92
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 49.65
Net increase (decrease) in cash and cash equivalents 2,621.57
Cash and cash equivalents cash flow statement at beginning of period 334.36
Cash and cash equivalents cash flow statement at end of period 2,955.93